peptidylprolyl isomerase inhibitor (Mitopharm)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepeptidylprolyl isomerase inhibitor (Mitopharm)
Drug Alias NamePPIase inhibitor (Mitopharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidylprolyl isomerase inhibitors
TargetsPeptidylprolyl isomerase
Therapy Area/IndicationsIschemiaReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitopharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitopharm Ltd
Active IndicationsN/A
Inactive IndicationsIschemiaReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A